BioCentury
ARTICLE | Clinical News

Exocell regulatory update

June 17, 1996 7:00 AM UTC

Exocell received U.S. Patent No. 5,518,720 covering treatment with its A717 monoclonal antibody for kidney disease and other complications of diabetes. The MAb binds to and neutralizes glycated album...